The company said it had used its machine learning platform to generate multiple antibodies and peptides against the Covid-19 virus in less than 17 days and could potentially create hitherto "impossible" protein-based therapeutics.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,